Tag #Nivolumab

Showing 1 to 3 of 3 results

kathimerini.gr
🌐 85% Global Worthiness
News related image

NHS England to Offer Faster Injectable Cancer Immunotherapy to 15,000 Patients Annually

The NHS England will provide up to 15,000 cancer patients annually with injectable nivolumab, a faster, more efficient immunotherapy for 15 cancer types, saving significant treatment time and freeing up hospital resources, at no extra cost to the NHS.

Progress

40% Bias Score

Good Health and Well-being
napoli.repubblica.it
🌐 85% Global Worthiness
News related image

Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma

In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.

Progress

48% Bias Score

Good Health and Well-being
theguardian.com
🌐 85% Global Worthiness
News related image

NHS England Offers Injectable Cancer Immunotherapy

NHS England becomes the first in Europe to offer injectable nivolumab, an immunotherapy, to treat up to 15,000 cancer patients annually, saving significant time compared to intravenous infusions and improving patient access.

Progress

40% Bias Score

Good Health and Well-being

Showing 1 to 3 of 3 results